4.7 Article

Clinical Efficacy, Tolerability and Safety of a New Multiple-Action Eyedrop in Subjects with Moderate to Severe Dry Eye

Related references

Note: Only part of the references are listed.
Review Ophthalmology

Hyaluronic acid in the treatment of dry eye disease

Leif Hynnekleiv et al.

Summary: This review evaluates the safety and efficacy of artificial tears containing hyaluronic acid (HA) in the treatment of dry eye disease (DED). The results show that artificial tears with 0.1% to 0.4% HA are effective in improving both signs and symptoms of DED, with no major complications or adverse events reported. However, two major gaps in the literature have been identified: the ideal drop frequency for HA-containing eyedrops has not been studied, and there is insufficient evidence to recommend any specific HA formulation over another. Future research should focus on exploring the optimal drop frequency for different concentrations and molecular weights of HA, as well as different drop formulations, taking into account DED severity and etiology.

ACTA OPHTHALMOLOGICA (2022)

Article Ophthalmology

Effects of a New Formulation of Multiple-Action Tear Substitute on Objective Ocular Surface Parameters and Ocular Discomfort Symptoms in Patients with Dry Eye Disease

Luca Vigo et al.

Summary: This study evaluated the efficacy and tolerability of Trimix eye drops in patients with dry eye disease. The results showed that two-month treatment with the Trimix formulation improved objective signs and subjective symptoms of the disease, and had good tolerability.

OPHTHALMOLOGY AND THERAPY (2022)

Review Ophthalmology

Modern approach to the treatment of dry eye, a complex multifactorial disease: a PICASSO board review

Pasquale Aragona et al.

Summary: Dry eye disease is a growing public health concern with significant socio-economic impact, characterized by tear film instability and ocular surface inflammation. Treatment should focus on restoring ocular surface homeostasis while considering factors such as epithelial damage and nerve damage.

BRITISH JOURNAL OF OPHTHALMOLOGY (2021)

Review Environmental Sciences

A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome

Yun-Jung Yang et al.

Summary: Hyaluronic acid eye drops are more effective in treating dry eye disease compared to non-hyaluronic acid eye drops, significantly improving tear production and tear stability time. Additional research is needed to further evaluate efficacy based on factors such as age, treatment duration, severity of dry eye, and optimal dosages.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Review Pharmacology & Pharmacy

Formulation Considerations for the Management of Dry Eye Disease

Priyanka Agarwal et al.

Summary: Dry eye disease is a common ocular surface disorder characterized by a lack of tear quality and/or quantity. Treatment typically involves multiple interventions, with artificial tears being the first line of therapy, but the development of eyedrops faces challenges due to low bioavailability and potential ocular toxicity from excipients.

PHARMACEUTICS (2021)

Review Chemistry, Multidisciplinary

Advances in the Noninvasive Diagnosis of Dry Eye Disease

Luca Di Cello et al.

Summary: Dry eye disease is a multifactorial disease that is commonly encountered in clinical practice. Traditional diagnostic tests have limitations, but new imaging technologies offer objective and multimodal approaches. This review summarizes current and emerging diagnostic tools for DED.

APPLIED SCIENCES-BASEL (2021)

Review Biochemistry & Molecular Biology

Trehalose for Ocular Surface Health

Jarmo Laihia et al.

BIOMOLECULES (2020)

Review Ophthalmology

Cross-Linked Hyaluronic Acid as Tear Film Substitute

Chiara Posarelli et al.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)

Article Ophthalmology

Physicochemical Properties of Hyaluronic Acid-Based Lubricant Eye Drops

Pasquale Aragona et al.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2019)

Article Pharmacology & Pharmacy

In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery

Bisera Jurisic Dukovski et al.

ACTA PHARMACEUTICA (2019)

Review Medicine, General & Internal

Dry Eye

Janine A. Clayton

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Biochemistry & Molecular Biology

Dry Eye Management: Targeting the Ocular Surface Microenvironment

Xiaobo Zhang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Ophthalmology

Tear Film Stability in Sjogren Syndrome Patients Treated with Hyaluronic Acid Versus Crosslinked Hyaluronic Acid-Based Eye Drops

Carlo Cagini et al.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2017)

Review Ophthalmology

Relevance of Lipid-Based Products in the Management of Dry Eye Disease

Jean-Sebastien Garrigue et al.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2017)

Review Ophthalmology

TFOS DEWS II Epidemiology Report

Fiona Stapleton et al.

OCULAR SURFACE (2017)

Review Ophthalmology

TFOS DEWS II Definition and Classification Report

Jennifer P. Craig et al.

OCULAR SURFACE (2017)

Article Ophthalmology

Impact of dry eye syndrome on vision-related quality of life

Biljana Miljanovic et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)

Article Medicine, General & Internal

Hormone replacement therapy and dry eye syndrome

DA Schaumberg et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)